Weiwei Hu
Research Subjects
Research Interests
Weiwei Hu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Xianliang Yan
Department of Emergency Medicine
2 shared publications- Xiaotong Wang
Department of Cardiology
2 shared publications - Yang Zhang
Department of Critical Care Medicine
2 shared publications Baohe Zang
Department of Critical Care Medicine
1 shared publicationDing Yuan
Department of Critical Care Medicine
1 shared publication- Jia Wang
Affiliation Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
1 shared publication
Latest Publications
- Open Access
- 16 November 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 7644535
Predictive Value of Arterial Blood Lactic Acid Concentration on the Risk of in‐Hospital All‐Cause Death in Patients with Acute Heart Failure
The study aims to examine the predictive value of arterial blood lactic acid concentration for in‐hospital all‐cause mortality in the intensive care unit (ICU) for patients with acute heart failure (AHF). We retrospectively analyzed the clinical data of 7558 AHF patients in the Medical Information Mart for Intensive Care IV (MIMIC‐IV) database. The exposure variable of the present study was arterial blood lactic acid concentration and the outcome variable was in‐hospital all‐cause death. The patients were divided into those who survived (n = 6792) and those who died (n = 766). The multivariate logistic regression model, restricted cubic spline (RCS) plot, and subgroup analysis were used to evaluate the association between lactic acid and in‐hospital all‐cause mortality. In addition, receiver operating curve (ROC) analysis also was performed. Finally, we further explore the association between NT‐proBNP and lactic acid and in‐hospital all‐cause mortality. Compared with the lowest quartiles, the odds ratios with 95% confidence intervals for in‐hospital all‐cause mortality across the quartiles were 1.46 (1.07–2.00), 1.48 (1.09–2.00), and 2.36 (1.73–3.22) for lactic acid, and in‐hospital all‐cause mortality was gradually increased with lactic acid levels increasing (P for trend P for interaction r = 0.07) and positively correlated with in‐hospital all‐cause mortality (r = 0.18). There was an inverse L‐shaped curve relationship between NT‐proBNP and in‐hospital all‐cause mortality, respectively. Mediation analysis suggested that a positive relationship between lactic acid and in‐hospital all‐cause death was mediated by NT‐proBNP. For AHF patients in the ICU, the arterial blood lactic acid concentration during hospitalization was a significant independent predictor of in‐hospital all‐cause mortality. The combination of lactic acid and SAPS II can improve the predictive value of the risk of in‐hospital all‐cause mortality in patients with AHF.
- 16 November 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 7644535
Open AccessPredictive Value of Arterial Blood Lactic Acid Concentration on the Risk of in‐Hospital All‐Cause Death in Patients with Acute Heart Failure
The study aims to examine the predictive value of arterial blood lactic acid concentration for in‐hospital all‐cause mortality in the intensive care unit (ICU) for patients with acute heart failure (AHF). We retrospectively analyzed the clinical data of 7558 AHF patients in the Medical Information Mart for Intensive Care IV (MIMIC‐IV) database. The exposure variable of the present study was arterial blood lactic acid concentration and the outcome variable was in‐hospital all‐cause death. The patients were divided into those who survived (n = 6792) and those who died (n = 766). The multivariate logistic regression model, restricted cubic spline (RCS) plot, and subgroup analysis were used to evaluate the association between lactic acid and in‐hospital all‐cause mortality. In addition, receiver operating curve (ROC) analysis also was performed. Finally, we further explore the association between NT‐proBNP and lactic acid and in‐hospital all‐cause mortality. Compared with the lowest quartiles, the odds ratios with 95% confidence intervals for in‐hospital all‐cause mortality across the quartiles were 1.46 (1.07–2.00), 1.48 (1.09–2.00), and 2.36 (1.73–3.22) for lactic acid, and in‐hospital all‐cause mortality was gradually increased with lactic acid levels increasing (P for trend P for interaction r = 0.07) and positively correlated with in‐hospital all‐cause mortality (r = 0.18). There was an inverse L‐shaped curve relationship between NT‐proBNP and in‐hospital all‐cause mortality, respectively. Mediation analysis suggested that a positive relationship between lactic acid and in‐hospital all‐cause death was mediated by NT‐proBNP. For AHF patients in the ICU, the arterial blood lactic acid concentration during hospitalization was a significant independent predictor of in‐hospital all‐cause mortality. The combination of lactic acid and SAPS II can improve the predictive value of the risk of in‐hospital all‐cause mortality in patients with AHF.
- Open Access
- 13 October 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 8384306
The Association between Standardized Serum 25‐Hydroxyvitamin D Concentration and Risk of Anemia: A Population‐Based Cross‐Sectional Study
The relationship between standardized serum 25‐hydroxyvitamin D (25(OH)D) concentration and incident anemia in the United States (U.S.) is unclear. The purpose of our study was to examine the association between serum 25(OH)D and anemia risk. We performed a cross‐sectional analysis of the U.S. population participating in the National Health and Nutrition Examination Survey (NHANES) between 2001 and 2018. A generalized linear model and restricted cubic spline (RCS) plot curve were constructed to assess the relationship between serum 25(OH)D concentration and anemia incidence. Additionally, the association between serum 25(OH)D concentration and red blood cell (RBC) count and hemoglobin (HB) levels was investigated using generalized additive models with smooth functions. Subgroup analysis also was performed. A total of 29933 individuals were included in our research. After adjusting for known confounding variables, compared with the lowest quartile, the odds ratios (ORs) with 95% confidence intervals (CIs) for association of serum 25(OH)D with anemia across the second, third, and fourth quartiles were 0.735 (0.651, 0.829), 0.527 (0.461, 0.602), and 0.696 (0.611, 0.792), respectively. Serum 25(OH)D concentration was associated with anemia risk in a U‐shaped pattern, as shown by an RCS plot (P for nonlinearity D supplementation.
- 13 October 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 8384306
Open AccessThe Association between Standardized Serum 25‐Hydroxyvitamin D Concentration and Risk of Anemia: A Population‐Based Cross‐Sectional Study
The relationship between standardized serum 25‐hydroxyvitamin D (25(OH)D) concentration and incident anemia in the United States (U.S.) is unclear. The purpose of our study was to examine the association between serum 25(OH)D and anemia risk. We performed a cross‐sectional analysis of the U.S. population participating in the National Health and Nutrition Examination Survey (NHANES) between 2001 and 2018. A generalized linear model and restricted cubic spline (RCS) plot curve were constructed to assess the relationship between serum 25(OH)D concentration and anemia incidence. Additionally, the association between serum 25(OH)D concentration and red blood cell (RBC) count and hemoglobin (HB) levels was investigated using generalized additive models with smooth functions. Subgroup analysis also was performed. A total of 29933 individuals were included in our research. After adjusting for known confounding variables, compared with the lowest quartile, the odds ratios (ORs) with 95% confidence intervals (CIs) for association of serum 25(OH)D with anemia across the second, third, and fourth quartiles were 0.735 (0.651, 0.829), 0.527 (0.461, 0.602), and 0.696 (0.611, 0.792), respectively. Serum 25(OH)D concentration was associated with anemia risk in a U‐shaped pattern, as shown by an RCS plot (P for nonlinearity D supplementation.